Dwyer Wendy 4
4 · Surface Oncology, Inc. · Filed May 2, 2019
Insider Transaction Report
Form 4
Dwyer Wendy
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-05-01+125,000→ 125,000 totalExercise: $4.77Exp: 2029-05-01→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]25% of this option shall become exercisable on April 1, 2020 and the remaining 75% shall vest in 36 equal monthly installments thereafter.